SlideShare a Scribd company logo
1 of 17
PRISM Contextual factors and
RE-AIM outcomes
RE-AIM and PRISM guide users to plan, implement, evaluate, and sustain
programs with contextual factors in mind, increasing equity and public
health relevance
www.re-aim.org
1. RE-AIM and PRISM in one slide
2. Core issues in Understanding RE-AIM
3. How RE-AIM evolved into PRISM
4. Frequent misunderstandings and clarifying
issues
5. How does RE-AIM address health equity?
What’s
Available in this
Slide Deck
Introduced in 2008,
PRISM expands RE-AIM
to consider context.
What is PRISM video
here or click icon to left:
https://www.youtube.co
m/watch?v=6qlWtzdxcS
o
Changing Internal
Context
Changing External
Context
Fit Among
Intervention
components
Implementation
strategies
Inner and outer
context
RE-AIM dimensions
Cross Cutting Issues
Proportion who benefit
Representativeness of
who benefits
Reasons: how and why
they benefit
Adaptations made
Costs incurred
PRISM =
Practical, Robust
Implementation and
Sustainability Model
Feldstein & Glasgow (2008). Joint Commission J on Qual. & Patient Safety, 34:
228-43.; Glasgow, RE, et al. RE-AIM Planning and Evaluation Framework: 20-
Year Review. Front Public Health 2019 7, 64. doi:10.3389/fpubh.2019.00064
What are the Core Issues In Understanding
RE-AIM and PRISM?
Purpose
Definitions
Why all dimensions
are important
Pragmatic use
Next few slides illustrate:
Facilitate translation of
research to practice.
Balance internal and
external validity.
Emphasize
representativeness and
equity.
Address multi-level
contextual factors:
individual, organizational,
system: experimental and
observational.
RE-AIM
RE-AIM Story about Implementing An Evidence-Based
Program (or Obesity Tx ; or COVID-19 Vaccine)
Even if 100% effective... is only so good as how and whether:
• It is adopted widely, including in low resource settings
• Local stakeholders and delivery staff choose to deliver it
• It can be implemented consistently with quality
• Intended recipients, including those at highest risk receive it
• It can be sustained
If we optimistically assume 70% success for each step above…
Glasgow RE, Vogt TM, Boles SM. Am J Public Health. 1999;89(9):1322
Glasgow RE, et al. Frontiers Public Health 2019 7:64. doi: 10.3389/fpubh.2019.00064
.7x
Overall Impact: = 17% benefit to society
.7x .7x .7x .7x
RE-AIM Dimension Key Pragmatic Definitions and Priorities to Consider and Answer
Reach
WHO is (was) intended to benefit and who actually participates or is exposed to the intervention
(intervention = program, policy, practice, pill, policies, principles, procedures, or product)
Effectiveness WHAT is (was) the most important benefit you are trying to achieve and what is (was) the
likelihood of negative outcomes?
Adoption
WHERE is (was) the intervention applied
WHO applied it?
Implementation
HOW consistently is (was) the intervention delivered?
HOW will (was) it be adapted?
HOW much will (did) it cost?
WHY will (did) the results come about?
Maintenance
WHEN will (was) the intervention become operational; how long will (was) it be sustained
(setting level); and how long are the results sustained (individual level)?
Pragmatic Use of RE-AIM- What is Feasible?
Glasgow RE & Estabrooks, P. Preventing Chronic Disease, 2018; 15: E02
ADOPTION
Technical Definition
The absolute number,
proportion, and
representativeness of
settings and agents willing to
initiate a program, and the
reasons why (qualitative).
Pragmatic Use
WHERE is the program
applied and
WHO applied it?
Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care... Prev Chronic Dis 2018;15:170271. DOI:
http://dx.doi.org/10.5888/pcd15.17027
Each RE-AIM Dimension has both Technical (research) and Pragmatic (user
friendly) definitions. For example:
Lessons learned from different outcomes across settings
Changing and additional emphases over time (especially adaptations,
costs, equity, sustainability, and context)
What is PRISM video
here or click icon to left:
https://www.youtube.co
m/watch?v=6qlWtzdxcS
o
RE-AIM.org
Glasgow RE, Vogt TM, Boles SM. Am J Public Health. 1999;89(9):1322
Glasgow RE, et al. Frontiers Public Health 2019 7:64. doi: 10.3389/fpubh.2019.00064
How has RE-AIM evolved into PRISM?
Research from 2000 – 2006 using RE-AIM
in different settings observed different
outcomes both across and within types of
settings- e.g. worksites, primary care,
dental offices, community settings
This despite evaluating the exact same
intervention, often delivered by similar or
same staff with high fidelity to protocol
PRISM drew from existing models:
-Diffusion of Innovations
-Model for Health Care Improvement
-Chronic Care Model
Feldstein & Glasgow (2008). Joint Commission J on Qual. & Patient Safety, 34: 228-43.
Summary of Evolution
Where are we today?
• One of the most widely used frameworks.
• Often mandated by funders.
• Expanded the original model to focus on
adaptions and sustainability.
• Emphasize qualitative methods to understand
“how” and “why.”
• Capture costs.
• Understand health equity issues.
• Encourage pragmatic use.
• Package RE-AIM for use by non-researchers.
• Integrate RE-AIM with other models.
Glasgow et al. RE-AIM Planning and Evaluation Framework: Adapting to New Science and
Practice with a 20-Year Review. Front Public Health. 2019;7:64.
Common misconceptions about RE-AIM and PRISM
Common misconceptions video
here or click icon to left:
https://www.youtube.com/watch?
v=-kwbiPVy2kk
Only for
evaluation
Only quantitative
Mandates that all
dimensions are
equally important
Does not address
health equity
RE-AIM—Health Equity Implications
RE-AIM Issue Disparity Overall Impact
Reach 30% 70% benefit
Effectiveness 0 (equal) 70% benefit
Adoption 30% 49% benefit
Implementation 30% 34% benefit
Maintenance 30% 24% benefit
Take Home Message: Equity issues at EACH STAGE of RE-AIM
ADOPTION
# and type of settings that
participate
IMPLEMENTATION
Consistently deliver
intervention and resources
with quality
REACH
(equity)
# and type of citizens and
families that participate
EFFECTIVENESS
(equity)
# and type of citizen and
families that benefit
(on what outcomes)
MAINTENANCE
Long-term implementation
and effectiveness
RE-AIM
Outcomes Cascade
⁼ RE-AIM steps
in cascade
⁼ Gaps or steps where
impact is lost
⁼ Potential ways to
minimize drop-off
Make implementation simple, low
cost and burden, and provide
support
Utilize evidence-based
resources and strategies;
make data-based adaptations
Provide ongoing
feedback, support and
resources for
implementation
Multiple and diverse tailored
promotion channels and
increased access
Tailor to and engage leaders,
stakeholders and address
history
Summary
• Outcomes framework (RE-
AIM) and Context
framework (PRISM).
• For planning,
implementation,
dissemination, sustainment,
equity, and evaluation.
• Has and will evolve to
address new issues and
challenges
RE-AIM outcomes and PRISM contextual factors
Key RE-AIM
References
• Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact…the RE-AIM framework.
Am J Public Health. 1999 Sep;89(9):1322-7.
• Estabrooks PA, Glasgow RE. Translating effective clinic-based physical activity... Am J Prev Med.
2006 31 (4 Suppl.):S45–56. doi: 10.1016/j.amepre.2006.06.019
• Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM)
for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008 Apr;34(4):228-43.
doi: 10.1016/s1553-7250(08)34030-6. PMID: 18468362.
• Shoup JA, et al. Network analysis of REAIM framework. Transl Behav Med. 2015 5:216–32. doi:
10.1007/s13142-014-0300-1
• Ory MG, et al. Perceived utility of the RE-AIM framework…for older adults... Front Public Health.
2015 2:143. doi: 10.3389/fpubh.2014.00143
• Harden, et al. Fidelity to and comparative results across behavioral interventions…: a systematic
review. Syst Rev. 2015 4:155. doi: 10.1186/s13643-015-0141-0
• Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care... Prev Chronic Dis
2018;15:170271. DOI: http://dx.doi.org/10.5888/pcd15.170271
• Glasgow, RE, et al. RE-AIM Planning and Evaluation Framework: 20-Year Review. Front Public
Health 2019 7, 64. doi:10.3389/fpubh.2019.00064
• Holtrop JS, Estabrooks P, Harden SM, Gaglio B, Kessler R, King D, Kwan BM, Ory M, Rabin B,
Shelton RC, Glasgow RE. Understanding and Applying the RE-AIM Framework: Misconceptions,
Clarifications, and Future Directions. . Journal of Clinical and Translational Science. 2021 5: e126,
1–10. doi: 10.1017/cts.2021.789
Special issue on RE-AIM in Frontiers of Public Health in 2020: Contains 21 articles.
• FAQ’s
• Guidance on application
• Searchable list of 700+ article abstracts.
• Calculators, checklists, tools.
• Webinars, upcoming events, blogs.
Tour of full website here:
https://www.youtube.com/watc
h?v=opkSz4OyvzM&t=5s

More Related Content

Similar to RE-AIM-and-PRISM-Guidance description.pptx

Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docx
Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docxAssignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docx
Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docxjesuslightbody
 
Studying implementation 2017
Studying implementation 2017Studying implementation 2017
Studying implementation 2017Martha Seife
 
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomesEvaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomescheweb1
 
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...HPCareer.Net / State of Wellness Inc.
 
· define the terms sample and population and describe some of
· define the terms sample and population and describe some of · define the terms sample and population and describe some of
· define the terms sample and population and describe some of LesleyWhitesidefv
 
4Theory of Unpleasant SymptomsNameInstitutio
4Theory of Unpleasant SymptomsNameInstitutio4Theory of Unpleasant SymptomsNameInstitutio
4Theory of Unpleasant SymptomsNameInstitutiomilissaccm
 
SAFE 1 - Introducing Quality Improvement - a presentation.pptx
SAFE 1 - Introducing Quality Improvement - a presentation.pptxSAFE 1 - Introducing Quality Improvement - a presentation.pptx
SAFE 1 - Introducing Quality Improvement - a presentation.pptxJABEED P
 
Webinar 4: Identifying barriers and enablers, and determinants, in theory
Webinar 4: Identifying barriers and enablers, and determinants, in theory 	     Webinar 4: Identifying barriers and enablers, and determinants, in theory
Webinar 4: Identifying barriers and enablers, and determinants, in theory Canadian Patient Safety Institute
 
Conquering the NHMRC grant impact elements
Conquering the NHMRC grant impact elementsConquering the NHMRC grant impact elements
Conquering the NHMRC grant impact elementsResearch Impact Academy
 
PrEP Implementation Planning for the US
PrEP Implementation Planning for the USPrEP Implementation Planning for the US
PrEP Implementation Planning for the USCHAMP Network
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
httpsdoi.org10.11771090198117709885Health Education &
httpsdoi.org10.11771090198117709885Health Education &httpsdoi.org10.11771090198117709885Health Education &
httpsdoi.org10.11771090198117709885Health Education &PazSilviapm
 
QI theories relevant to PPE compliance
QI theories relevant to PPE complianceQI theories relevant to PPE compliance
QI theories relevant to PPE compliancelexie_daryan
 
Medical Simulation 2.0: Improving value-based healthcare delivery
Medical Simulation 2.0:  Improving value-based healthcare deliveryMedical Simulation 2.0:  Improving value-based healthcare delivery
Medical Simulation 2.0: Improving value-based healthcare deliveryYue Dong
 
Implementation strategies
Implementation strategiesImplementation strategies
Implementation strategiesMartha Seife
 
Expert-System for Health Promotion
Expert-System for Health PromotionExpert-System for Health Promotion
Expert-System for Health PromotionJoel Bennett
 
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docx
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docxChapter 5 Program Evaluation and Research TechniquesCharlene R. .docx
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docxchristinemaritza
 

Similar to RE-AIM-and-PRISM-Guidance description.pptx (20)

Plenary Day 1 Speaker 1 Hal Sox
Plenary Day 1 Speaker 1 Hal SoxPlenary Day 1 Speaker 1 Hal Sox
Plenary Day 1 Speaker 1 Hal Sox
 
Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docx
Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docxAssignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docx
Assignment WK 9Assessing a Healthcare ProgramPolicy Evaluation.docx
 
Studying implementation 2017
Studying implementation 2017Studying implementation 2017
Studying implementation 2017
 
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomesEvaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
 
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...
Planning, Implementing, and Evaluation Using the RE-AIM Framework with Samant...
 
· define the terms sample and population and describe some of
· define the terms sample and population and describe some of · define the terms sample and population and describe some of
· define the terms sample and population and describe some of
 
4Theory of Unpleasant SymptomsNameInstitutio
4Theory of Unpleasant SymptomsNameInstitutio4Theory of Unpleasant SymptomsNameInstitutio
4Theory of Unpleasant SymptomsNameInstitutio
 
SAFE 1 - Introducing Quality Improvement - a presentation.pptx
SAFE 1 - Introducing Quality Improvement - a presentation.pptxSAFE 1 - Introducing Quality Improvement - a presentation.pptx
SAFE 1 - Introducing Quality Improvement - a presentation.pptx
 
Webinar 4: Identifying barriers and enablers, and determinants, in theory
Webinar 4: Identifying barriers and enablers, and determinants, in theory 	     Webinar 4: Identifying barriers and enablers, and determinants, in theory
Webinar 4: Identifying barriers and enablers, and determinants, in theory
 
Conquering the NHMRC grant impact elements
Conquering the NHMRC grant impact elementsConquering the NHMRC grant impact elements
Conquering the NHMRC grant impact elements
 
PrEP Implementation Planning for the US
PrEP Implementation Planning for the USPrEP Implementation Planning for the US
PrEP Implementation Planning for the US
 
Agreeing what outcomes to measure
Agreeing what outcomes to measureAgreeing what outcomes to measure
Agreeing what outcomes to measure
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
httpsdoi.org10.11771090198117709885Health Education &
httpsdoi.org10.11771090198117709885Health Education &httpsdoi.org10.11771090198117709885Health Education &
httpsdoi.org10.11771090198117709885Health Education &
 
Assessing Applicability
Assessing ApplicabilityAssessing Applicability
Assessing Applicability
 
QI theories relevant to PPE compliance
QI theories relevant to PPE complianceQI theories relevant to PPE compliance
QI theories relevant to PPE compliance
 
Medical Simulation 2.0: Improving value-based healthcare delivery
Medical Simulation 2.0:  Improving value-based healthcare deliveryMedical Simulation 2.0:  Improving value-based healthcare delivery
Medical Simulation 2.0: Improving value-based healthcare delivery
 
Implementation strategies
Implementation strategiesImplementation strategies
Implementation strategies
 
Expert-System for Health Promotion
Expert-System for Health PromotionExpert-System for Health Promotion
Expert-System for Health Promotion
 
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docx
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docxChapter 5 Program Evaluation and Research TechniquesCharlene R. .docx
Chapter 5 Program Evaluation and Research TechniquesCharlene R. .docx
 

Recently uploaded

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trssuser06f238
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tanta
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tantaDashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tanta
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tantaPraksha3
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsssuserddc89b
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 

Recently uploaded (20)

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 tr
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tanta
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tantaDashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tanta
Dashanga agada a formulation of Agada tantra dealt in 3 Rd year bams agada tanta
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physics
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 

RE-AIM-and-PRISM-Guidance description.pptx

  • 1. PRISM Contextual factors and RE-AIM outcomes RE-AIM and PRISM guide users to plan, implement, evaluate, and sustain programs with contextual factors in mind, increasing equity and public health relevance www.re-aim.org
  • 2. 1. RE-AIM and PRISM in one slide 2. Core issues in Understanding RE-AIM 3. How RE-AIM evolved into PRISM 4. Frequent misunderstandings and clarifying issues 5. How does RE-AIM address health equity? What’s Available in this Slide Deck
  • 3. Introduced in 2008, PRISM expands RE-AIM to consider context. What is PRISM video here or click icon to left: https://www.youtube.co m/watch?v=6qlWtzdxcS o Changing Internal Context Changing External Context Fit Among Intervention components Implementation strategies Inner and outer context RE-AIM dimensions Cross Cutting Issues Proportion who benefit Representativeness of who benefits Reasons: how and why they benefit Adaptations made Costs incurred PRISM = Practical, Robust Implementation and Sustainability Model Feldstein & Glasgow (2008). Joint Commission J on Qual. & Patient Safety, 34: 228-43.; Glasgow, RE, et al. RE-AIM Planning and Evaluation Framework: 20- Year Review. Front Public Health 2019 7, 64. doi:10.3389/fpubh.2019.00064
  • 4. What are the Core Issues In Understanding RE-AIM and PRISM? Purpose Definitions Why all dimensions are important Pragmatic use Next few slides illustrate:
  • 5. Facilitate translation of research to practice. Balance internal and external validity. Emphasize representativeness and equity. Address multi-level contextual factors: individual, organizational, system: experimental and observational. RE-AIM
  • 6. RE-AIM Story about Implementing An Evidence-Based Program (or Obesity Tx ; or COVID-19 Vaccine) Even if 100% effective... is only so good as how and whether: • It is adopted widely, including in low resource settings • Local stakeholders and delivery staff choose to deliver it • It can be implemented consistently with quality • Intended recipients, including those at highest risk receive it • It can be sustained If we optimistically assume 70% success for each step above… Glasgow RE, Vogt TM, Boles SM. Am J Public Health. 1999;89(9):1322 Glasgow RE, et al. Frontiers Public Health 2019 7:64. doi: 10.3389/fpubh.2019.00064 .7x Overall Impact: = 17% benefit to society .7x .7x .7x .7x
  • 7. RE-AIM Dimension Key Pragmatic Definitions and Priorities to Consider and Answer Reach WHO is (was) intended to benefit and who actually participates or is exposed to the intervention (intervention = program, policy, practice, pill, policies, principles, procedures, or product) Effectiveness WHAT is (was) the most important benefit you are trying to achieve and what is (was) the likelihood of negative outcomes? Adoption WHERE is (was) the intervention applied WHO applied it? Implementation HOW consistently is (was) the intervention delivered? HOW will (was) it be adapted? HOW much will (did) it cost? WHY will (did) the results come about? Maintenance WHEN will (was) the intervention become operational; how long will (was) it be sustained (setting level); and how long are the results sustained (individual level)? Pragmatic Use of RE-AIM- What is Feasible? Glasgow RE & Estabrooks, P. Preventing Chronic Disease, 2018; 15: E02
  • 8. ADOPTION Technical Definition The absolute number, proportion, and representativeness of settings and agents willing to initiate a program, and the reasons why (qualitative). Pragmatic Use WHERE is the program applied and WHO applied it? Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care... Prev Chronic Dis 2018;15:170271. DOI: http://dx.doi.org/10.5888/pcd15.17027 Each RE-AIM Dimension has both Technical (research) and Pragmatic (user friendly) definitions. For example:
  • 9. Lessons learned from different outcomes across settings Changing and additional emphases over time (especially adaptations, costs, equity, sustainability, and context) What is PRISM video here or click icon to left: https://www.youtube.co m/watch?v=6qlWtzdxcS o RE-AIM.org Glasgow RE, Vogt TM, Boles SM. Am J Public Health. 1999;89(9):1322 Glasgow RE, et al. Frontiers Public Health 2019 7:64. doi: 10.3389/fpubh.2019.00064 How has RE-AIM evolved into PRISM?
  • 10. Research from 2000 – 2006 using RE-AIM in different settings observed different outcomes both across and within types of settings- e.g. worksites, primary care, dental offices, community settings This despite evaluating the exact same intervention, often delivered by similar or same staff with high fidelity to protocol PRISM drew from existing models: -Diffusion of Innovations -Model for Health Care Improvement -Chronic Care Model Feldstein & Glasgow (2008). Joint Commission J on Qual. & Patient Safety, 34: 228-43. Summary of Evolution
  • 11. Where are we today? • One of the most widely used frameworks. • Often mandated by funders. • Expanded the original model to focus on adaptions and sustainability. • Emphasize qualitative methods to understand “how” and “why.” • Capture costs. • Understand health equity issues. • Encourage pragmatic use. • Package RE-AIM for use by non-researchers. • Integrate RE-AIM with other models. Glasgow et al. RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice with a 20-Year Review. Front Public Health. 2019;7:64.
  • 12. Common misconceptions about RE-AIM and PRISM Common misconceptions video here or click icon to left: https://www.youtube.com/watch? v=-kwbiPVy2kk Only for evaluation Only quantitative Mandates that all dimensions are equally important Does not address health equity
  • 13. RE-AIM—Health Equity Implications RE-AIM Issue Disparity Overall Impact Reach 30% 70% benefit Effectiveness 0 (equal) 70% benefit Adoption 30% 49% benefit Implementation 30% 34% benefit Maintenance 30% 24% benefit Take Home Message: Equity issues at EACH STAGE of RE-AIM
  • 14. ADOPTION # and type of settings that participate IMPLEMENTATION Consistently deliver intervention and resources with quality REACH (equity) # and type of citizens and families that participate EFFECTIVENESS (equity) # and type of citizen and families that benefit (on what outcomes) MAINTENANCE Long-term implementation and effectiveness RE-AIM Outcomes Cascade ⁼ RE-AIM steps in cascade ⁼ Gaps or steps where impact is lost ⁼ Potential ways to minimize drop-off Make implementation simple, low cost and burden, and provide support Utilize evidence-based resources and strategies; make data-based adaptations Provide ongoing feedback, support and resources for implementation Multiple and diverse tailored promotion channels and increased access Tailor to and engage leaders, stakeholders and address history
  • 15. Summary • Outcomes framework (RE- AIM) and Context framework (PRISM). • For planning, implementation, dissemination, sustainment, equity, and evaluation. • Has and will evolve to address new issues and challenges RE-AIM outcomes and PRISM contextual factors
  • 16. Key RE-AIM References • Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact…the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322-7. • Estabrooks PA, Glasgow RE. Translating effective clinic-based physical activity... Am J Prev Med. 2006 31 (4 Suppl.):S45–56. doi: 10.1016/j.amepre.2006.06.019 • Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008 Apr;34(4):228-43. doi: 10.1016/s1553-7250(08)34030-6. PMID: 18468362. • Shoup JA, et al. Network analysis of REAIM framework. Transl Behav Med. 2015 5:216–32. doi: 10.1007/s13142-014-0300-1 • Ory MG, et al. Perceived utility of the RE-AIM framework…for older adults... Front Public Health. 2015 2:143. doi: 10.3389/fpubh.2014.00143 • Harden, et al. Fidelity to and comparative results across behavioral interventions…: a systematic review. Syst Rev. 2015 4:155. doi: 10.1186/s13643-015-0141-0 • Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care... Prev Chronic Dis 2018;15:170271. DOI: http://dx.doi.org/10.5888/pcd15.170271 • Glasgow, RE, et al. RE-AIM Planning and Evaluation Framework: 20-Year Review. Front Public Health 2019 7, 64. doi:10.3389/fpubh.2019.00064 • Holtrop JS, Estabrooks P, Harden SM, Gaglio B, Kessler R, King D, Kwan BM, Ory M, Rabin B, Shelton RC, Glasgow RE. Understanding and Applying the RE-AIM Framework: Misconceptions, Clarifications, and Future Directions. . Journal of Clinical and Translational Science. 2021 5: e126, 1–10. doi: 10.1017/cts.2021.789 Special issue on RE-AIM in Frontiers of Public Health in 2020: Contains 21 articles.
  • 17. • FAQ’s • Guidance on application • Searchable list of 700+ article abstracts. • Calculators, checklists, tools. • Webinars, upcoming events, blogs. Tour of full website here: https://www.youtube.com/watc h?v=opkSz4OyvzM&t=5s

Editor's Notes

  1. NOTE TO PRESENTER: YOU CAN ADAPT THIS LIST (e.g., perhaps remove slides 6-8 if already talking to a well-verse implementation science audience)
  2. NOTE TO PRESENTER: YOU CAN ADAPT THIS LIST (e.g., perhaps remove slides 6-8 if already talking to a well-verse implementation science audience)
  3. This slides contains a LOT of information, but lets break it down into its component parts and then we can ‘put it back together again and help explain the important interrelationships involved’ FIRST in the center of the figure we have the program or policy that is being studies or implemented; and immediately below it the set of implementation strategies that are used- at least initially SECOND- in the circle around these elements are the 5 RE-AIM implementation outcomes impacted by the INT and Imp strategies NEXT- at the top are the PRISM contextual factors that influence these outcomes. They are divided into: -External factors outside the immediate implementation setting such as relevant policies, guidelines, national priorities Internal context consists of both characteristics of both the setting, staff and patients or students, etc. -Importantly and unique about PRISM it also include structures and resources to support implementation and sustainability THEN the rectangle n the right hand side summarizes key or overarching issues that apply across all RE-AIM and PRISM dimensions- these include a focus on what percent of people or settings participate; equity issues around how representative they are; adaptations that are made before during and after an intervention, and the costs involved. FINALLY- the rectangle on the left reminds us that these various factors do not exist in isolation…but rather the key to success is the alignment among Tx, imp strategy, context and RE-AIM outcomes prioritized
  4. RE-AIM optimizes external validity and pragmatic criteria which are often ignored. By optimizing these crucial elements, RE-AIM serves several purposes: First, RE-AIM facilitates the translation of research to practice. It helps identify all the pieces to the puzzle. Second, RE-AIM balances internal and external validity so that results are empirically rigorous and practically meaningful. Third, RE-AIM emphasizes representativeness and issues related to access. Fourth, RE-AIM allows researchers to address multi-level factors. It captures implementation at the individual and organizational levels through experimental and observational methods.
  5. To illustrate, lets take a hypothetical example that we call ‘the RE-AIM story’… imagine that tomorrow morning you read a new definite multi-site RCT study that found an intervention in your areas was 100% effective- worked for every single individual in the study. Now lets walk through the steps involved for this 100% effective intervention to have impact on population health……… read or paraphrase lines
  6. There are detailed technical definitions of the various RE-AIM dimensions and components elsewhere in this website and an example on the next slide, but it is lso important for pragmatic use with research terms, non scientists community members that he key parts of PRISM > RE-AIM can be understood using more everyday language. To address this we have developed the practical definitions above- using the familiar who, what, when, where, how questions
  7. Now for an example lets take The third dimension of RE-AIM is adoption which is defined as the absolute number, proportion, and representativeness of settings and intervention agents who are willing to initiate a program. Pragmatically, the question for adoption is Where is the program applied and who applied it?
  8. The next 2 slides summarize key changes in PRISM > RE-AIM over its 20 years… it is important remember when referencing RE-AIM to refer to the website and to cite papers on RE-AIM- especially the 2 listed here…. And NOT just the original 1999 paper
  9. Over this 20-year journey, we have learned many lessons. Here are just a few: RE-AIM is one of the most common Dissemination and Implementation frameworks, and it is often mandated by funders. We’ve learned to expand the original model to focus on adaptations and long-term sustainability. There’s a growing emphasis on qualitative methods to more fully explore and understand the “how” and “why” of results. We need to capture costs and consider health equity issues. We’ve learned to encourage pragmatic use of the RE-AIM dimensions, and we continue to seek better ways to package RE-AIM so that’s useful and meaningful for diverse stakeholders, particularly non-researchers. Finally, we see the value of integrating RE-AIM with other models such as PRISM.
  10. This slide uses hypothetical data to illustrate the importance of broad thinking about outcomes. The importance of focusing on all five dimensions of RE-AIM – effectiveness is not the only important factor, especially in disparities. Basically it show that even- as if often reported- an intervention produces identical effects among participants of different characteristics… there can still be large inequities if there are disparities in the other RE-AIM outcomes- as can be seen…. Note if one only focused on effectiveness, one would likely conclude there were no health disparities associated with this program or policy; but in fact in this scenario the intervention would actually only produce less than ¼ of the long terms benefit for some groups as for others
  11. This final slide illustrates what we are now calling the ‘RE-AIM cascade; it show- in the order in which new programs, policies or products ae usually rolled out- e.g. adopted in certain settings, implemented by certain staff in certain ways, and reaches certain members of the target audience. This should sound familiar by now… but the point of this slide is that if one tracks what is happening and pays attention to RE-AIM outcomes- from the beginning and periodically during a program, steps can be taken to enhance the overall impact and the equity of a program…… The bottom line is each step in this cascade provides an opportunity to reduce inequities and increase impact We hope that you will find these slides of use when discussing RE-AIM with others and welcome your feedback on them
  12. To summarize: RE-AIM is an outcomes framework. RE-AIM can be used for planning, implementation, dissemination, and evaluation. RE-AIM can be used for observational, efficacy, effectiveness, and implementation research projects. RE-AIM is constantly evolving to address new issues and challenges such as rapid analysis, predictive modeling, and perspectives of diverse stakeholders.
  13. Here are eight key RE-AIM references. And we especially refer you to the special issue noted at the bottom
  14. Many additional resources are available at re-aim.org. At re-aim.org you can find: FAQ’s, Guidance on applying RE-AIM, including quantitative and qualitative approaches. A searchable list of 600+ RE-AIM article abstracts, plus a list of over 40 key publications. Various tools including calculators and checklists. Links to webinars, upcoming events, and blogs.